RTAC SEC filings, in plain English
Everything Renatus Tactical I has filed with the SEC that we hold — 40 filings, newest first, 38 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Quarterly report (Form 10-Q) filed by a blank-check company (SPAC) for the period ended June 30, 2026. Trust value per share increased from $10.28 to $10.45; net income of $3.53M from trust interest; cash outside trust only $477, leading to a going concern warning; no business combination announced; additional convertible notes of $380,000 issued in 2026; working capital deficit of $179,443. Why it matters: Investors should monitor trust accretion, liquidity risk, and the approaching business combination deadline of May 16, 2027. The going concern disclosure signals that the company may not have sufficient cash to operate without a deal or further financing.
What changed vs 2026-05-13trust $250.3M → $252.4M +1%trust account, combination deadline, going-concern doubt +31 moved · 5 with no prior record of ours
- Trust account
- $250.3M$252.4M
- Combination deadline
- not previously extracted2027-05-16
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $21Knot matched in this filing
- Mandate language
- focus its search on high potential businesses based in the U… · unchanged
- Redeemable shares
- 24.1M · unchanged
SpacBrain reads this as $2,105,683 was added to the trust between the two filings.
The clause …“from the issuance of convertible notes. As of June 30, 2026, we had cash held in the Trust Account of $252,380,649. We intend to use substantially all of the funds held in the trust account, including any amounts representing”…
The clause …“the Company to operate in the next twelve months. Additionally, the Company has until May 16, 2027, to complete a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with”…
The clause …“the Company to operate in the next twelve months. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed financial statements do not include any adjustments”…
The clause …“and contingencies (Note 7) Class A ordinary shares, $ 0.0001 par value; 24,150,000 shares subject to possible redemption at $ 10.45 and $ 10.28 per share as of June 30, 2026 and December 31, 2025, respectively 252,380,649”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A joint filing agreement (Exhibit A) attached to a Schedule 13G/A amendment, executed on August 14, 2026, by Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. (identified as Managing Member). The parties stipulate that statements on Schedule 13G regarding beneficial ownership of Renatus Tactical Acquisition Corp I, along with any future amendments including those on Schedule 13D, shall be filed on behalf of each signer pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934. The filing text contains no amendments to share quantities, voting power thresholds, acquisition costs, or financing arrangements. It reports no modifications to redemption windows, trust account distribution procedures, business combination deadlines, extension motions, target negotiation milestones, or sponsor governance disclosures. Per the document, the sole action recorded is the mutual agreement to coordinate future equity reporting through a single joint submission. Why it matters: While administratively routine, the agreement confirms that Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. are consolidating their regulatory disclosure obligations for their combined stake. Because the complete Schedule 13G/A amendment (which would disclose actual percentage ownership and purpose codes) is not included in this excerpt, investors cannot extract new position data from this exhibit alone. The document makes zero assertions regarding customer concentration, revenue forecasts, addressable market sizing, strategic pivot language, proprietary technology, partnership formations, litigation exposure, or executive compensation. As a procedural compliance instrument, it carries no direct implications for shareholder redemptions, trust reconciliation, or conversion timeline management.
What changed: Form 8-K Current Report filed under Item 5.02 of Regulation S-K announcing the appointment of a new board member, associated indemnification agreements, and sponsor-compensated directorship arrangements. Effective July 21, 2026, the Board appointed Lauren Selig as a director and assigned her to the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. According to the filing, Ms. Selig executed the standard indemnification agreement and became a signatory to the letter agreement dated May 14, 2025. The Company states that, under that agreement, she agreed to vote any Class A Ordinary Shares she holds in favor of the initial business combination, facilitate liquidation and winding up if a combination is not consummated within 24 months (or up to 30 months by resolution of the Board), and comply with specified transfer restrictions. The registrant reports that Ms. Selig receives no cash compensation for board services; instead, International SPAC Management Group I LLC, identified as the Company’s sponsor, will transfer 50,000 Class B ordinary shares to her. The filing makes no adjustments to the trust account, redemption provisions, warrant terms (each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50), or the stated class A ordinary share par value of $0.0001. Why it matters: The appointment brings board-level oversight to target selection, citing Ms. Selig’s 25 years of experience in entertainment, technology, artificial intelligence, blockchain, and venture investments since founding Shake and Bake Productions in 2013. Her execution of the existing letter agreement confirms continuity of the governance framework controlling shareholder voting and the dissolution timeline without altering the mechanical parameters of the trust or redemption calendar. The sponsor-funded issuance of 50,000 Class B ordinary shares functions as a non-dilutive-to-trust compensation mechanism and adjusts founder share ownership. Chief Executive Officer Eric Swider, who signed the report, attests that no family relationships exist between Ms. Selig and any other director or executive officer, and that her selection was not governed by any external arrangement or understanding. The document contains no assertions regarding pending negotiations, target industry focus, customer pipelines, revenue projections, partnership disclosures, or litigation exposure.
What changed: A Form 8-K current report concerning a director's resignation and resulting temporary noncompliance with Nasdaq listing standards. On June 5, 2026, Matan Fattal formally notified the Board of Directors of Renatus Tactical Acquisition Corp. I that he would resign as a director and as a member of the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, effective immediately. The registrant attributed the departure to no dispute or disagreement with management. His exit lowered the independent audit committee below the three-member minimum required by Nasdaq Listing Rule 5605(c)(2)(A) and left the full Board without a majority of independent directors. The company disclosed that the current Board holds two independent seats, two non-independent seats, and one vacancy. On June 8, 2026, the registrant informed Nasdaq of the compliance gaps and declared its intent to operate under the cure periods permitted by Nasdaq Listing Rules 5605(c)(4)(B) and 5605(b)(1)(A) while seeking a replacement independent director. Why it matters: The filing adjusts the sponsor's board composition and initiates a Nasdaq cure window without modifying the SPAC's underlying economics, redemption mechanics, or the May 16, 2027 deadline. Trust assets remain allocated at $10.45 per share, and investor redemption rights are unaffected. However, the governance vacuum introduces a short-term listing compliance risk that SPAC trackers should monitor; failure to staff the vacant seat within the Nasdaq-mandated cure periods could trigger delisting proceedings independent of any business combination timeline. The document contains no assertions regarding target customers, revenue streams, market sizing, operational strategy, proprietary technology, strategic partnerships, or active litigation, and records no officer compensation adjustments beyond the director's departure.
What changed: Quarterly report (Form 10-Q) for Renatus Tactical Acquisition Corp I, a blank-check SPAC, for the period ended March 31, 2026. Trust value per share increased from $10.28 at Dec 31, 2025 to $10.36 at Mar 31, 2026. Total trust cash rose from $248.18M to $250.27M. Net income of $1.81M for Q1 2026 vs $0 in Q1 2025. Cash outside trust fell to $10,977, prompting a going concern warning. A second convertible note of $80,000 (conversion at $5.00 per unit) was issued. A subsequent event on April 24, 2026: two additional convertible notes totaling $300,000 (8% interest, conversion at $3.00 per unit) were issued. No extension or deal announcement. No change in shares outstanding (24.15M Class A, 7.01M Class B). Deadlines unchanged (24 months from IPO = May 2027). Why it matters: Trust per-share value modestly rising signals interest accretion is ongoing. The new convertible notes (April 2026) at a $3.00 conversion price versus earlier $5.00 suggests investors are getting better terms, possibly indicating urgency. The going concern disclosure — only $10,977 outside trust — and the statement that this cash will not sustain operations for 12 months, materially raises the risk of forced liquidation if no deal closes soon. No business combination has been announced.
What changed vs 2025-11-19trust $245.9M → $250.3M +2%trust account, sponsor loans outstanding, going-concern doubt +21 moved · 4 with no prior record of ours
- Trust account
- $245.9M$250.3M
- Sponsor loans outstanding
- not previously extracted$21K
- Going-concern doubt
- stated · unchanged
- Mandate language
- focus its search on high potential businesses based in the U… · unchanged
- Redeemable shares
- 24.1M · unchanged
SpacBrain reads this as $4,418,141 was added to the trust between the two filings.
The clause …“from the issuance of a convertible note. As of March 31, 2026, we had cash held in the Trust Account of $250,274,966. We intend to use substantially all of the funds held in the trust account, including any amounts representing”…
The clause …“of operations. As of March 31, 2026 and December 31, 2025, the Company owed the Sponsor $ 21,460 and $ 8,000 , respectively, under the agreement, which is included in accrued expenses on the unaudited condensed balance sheets.”…
The clause …“the Company to operate in the next twelve months. These conditions raise substantial doubt about the Company s ability to continue as a going concern. These unaudited condensed financial statements do not include any adjustments”…
The clause …“and contingencies (Note 7) Class A ordinary shares, $ 0.0001 par value; 24,150,000 shares subject to possible redemption at $ 10.36 and $ 10.28 per share as of March 31, 2026 and December 31, 2025, respectively 250,274,966”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form 10-K annual report for the fiscal year ended December 31, 2025, filed by Renatus Tactical Acquisition Corp I, a SPAC still searching for a business combination. This is the company's first 10-K since its IPO on May 16, 2025. The IPO raised $241.5 million (24.15 million units at $10.00) and a concurrent private placement of 3.82 million warrants at $1.00 each raised $3.82 million. Net trust deposit was $242.1 million. As of December 31, 2025, trust assets totaled $248.2 million ($10.28 per public share). Cash outside the trust was only $4,031, with working capital of $388,033. The auditor issued a going concern opinion, stating cash is insufficient to operate for the next twelve months. Net income for 2025 was $5.06 million, primarily from interest income. No business combination has been announced. The company has until May 2027 (with possible extensions) to complete a deal. The 10-K documents extensive risk factors, including liquidity risk, sponsor conflicts (management ties to TMTG/Trump), and the ability to find a target. Why it matters: This is the first comprehensive annual report post-IPO, providing critical financial health metrics. The trust value of $10.28 per share is slightly below the $10.45 implied in the user's data, which may affect redemption calculations. The $4,031 cash balance and going concern warning highlight the urgency to complete a business combination or risk liquidation. The filing also confirms the sponsor's commitment to vote in favor of any deal and the absence of a minimum redemption threshold, which could enable a deal even with large redemptions. The focus on cryptocurrency/blockchain and data security sectors provides insight into potential targets. The report is material for investors tracking deadline, trust value, and sponsor conduct.
What changed: A Joint Filing Agreement (Exhibit A) attached to a Schedule 13G beneficial ownership report, executed by Harraden Circle Investments, LLC, its affiliated general partners, limited partnerships, and Frederick V. Fortmiller, Jr. The agreement authorizes a single Schedule 13G filing on behalf of all listed Harraden Circle entities and Mr. Fortmiller for their potential beneficial ownership of Renatus Tactical Acquisition Corp I securities, invoking Rule 13d-1(k). It discloses no share counts, percentage thresholds, acquisition dates, or transaction volumes. Regarding SPAC mechanics, the document contains zero references to redemption deadlines, trust account valuations, extension proposals, target identification progress, or sponsor conduct. The only substantive content is the administrative consolidation of reporting obligations among the named investment vehicles, with all assertions originating exclusively from the signatories themselves. Why it matters: For investors tracking redemption calendars, trust value, extension timelines, deal progress, or sponsor behavior, this filing introduces no operational or mechanical changes. It is a boilerplate compliance attachment that confirms a coordinated reporting bloc but intentionally omits the underlying Schedule 13G data required to assess voting intent, disposition plans, or alignment with management. Without the primary schedule, stakeholders cannot determine whether this group intends to participate in any future redemption wave, vote for an extension, or support a specific acquisition candidate. The filing updates SEC registration procedure but provides no signal on liquidity pressure, sponsor fiduciary conduct, or RTAC's path to deSPAC.
What changed: Quarterly report on Form 10-Q for the period ended September 30, 2025, filed by Renatus Tactical Acquisition Corp I, a blank check company (SPAC) searching for a business combination. The company completed its IPO on May 16, 2025, raising $241.5 million and placing $242.1 million in trust. The trust per-share value has accreted to $10.18 from the initial $10.025 per unit. The company has not yet identified a target. The company issued a $250,000 convertible note to an investor in July 2025. Cash outside trust is only $97,362, leading to substantial doubt about going concern. The company has 24 months from IPO (until May 2027) to complete a business combination, with possible two three-month extensions. Why it matters: The trust value per share ($10.18) is above the IPO price, providing a floor for redemptions. However, the company's very low cash on hand ($97,362) outside trust raises risk of running out of funds before a deal is announced, potentially forcing liquidation or a dilutive rescue loan. The convertible note ($250,000) converts at $5.00 per unit, which is a steep discount to trust value, indicating potential dilution for public shareholders if a deal is completed. The deadline is May 2027, but the company's financial condition may accelerate the need for a deal.
What changed vs 2025-08-13trust $243.3M → $245.9M +1%going concern APPEAREDtrust account, going-concern doubt, mandate language +12 moved · 2 with no prior record of ours
- Trust account
- $243.3M$245.9M
- Going-concern doubt
- not statedstated
- Mandate language
- focus its search on high potential businesses based in the U… · unchanged
- Redeemable shares
- 24.1M · unchanged
SpacBrain reads this as $2,512,269 was added to the trust between the two filings.
The clause …“the issuance of a convertible note. As of September 30, 2025, we had cash held in the Trust Account of $245,856,825. We intend to use substantially all of the funds held in the trust account, including any amounts representing”…
SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.
The clause …“the Company to operate in the next twelve months. These conditions raise substantial doubt about the Company s ability to continue as a going concern. These financial statements do not include any adjustments relating to the”…
The clause …“and contingencies (Note 6) Class A ordinary shares, $ 0.0001 par value; 24,150,000 and 0 shares subject to possible redemption at $ 10.18 per share as of September 30, 2025 and December 31, 2024, respectively 245,856,825 -”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: SEC Form 12b-25, a Notification of Late Filing for the Registrant’s Quarterly Report on Form 10-Q for the period ended September 30, 2025. Renatus Tactical Acquisition Corp I formally notified the SEC that it will miss the original filing deadline for its Q3 2025 10-Q. The registrant indicated that the Company and its external auditor require additional time to complete the final review of the financial statements and related disclosures. The filing commits to submitting the delayed report no later than the fifth calendar day following the prescribed due date. Why it matters: This notification does not trigger an automatic extension, alter the stated redemption deadline of May 16, 2027, or adjust the reported trust value of $10.45 per share. The delay reflects administrative and audit coordination rather than a structural change to the SPAC’s mechanics or business combination timeline.
What changed: Schedule 13G/A Joint Filing Agreement (Exhibit A) and associated beneficial ownership amendment cover identifiers. This document is a Joint Filing Agreement executed on August 14, 2025, by Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; and Frederick V. Fortmiller, Jr. Acting under Rule 13d-1(k), the seven affiliated entities and Mr. Fortmiller consolidate their SEC reporting into a single Schedule 13G/A submission. The provided text contains only the signature blocks and corporate chain-of-command declarations; it does not include the actual 13G/A schedule pages that would disclose aggregate share counts, percentage of outstanding common stock, date of last purchase, or stated acquisition purpose. Consequently, the filing does not modify RTAC’s $10.45 trust-per-share baseline, its May 16, 2027 redemption deadline, or its SEARCHING status. No amendments to sponsor arrangements, liquidation clocks, or de-SPAC timelines are referenced. Why it matters: Because the submission references a Schedule 13G (not a 13D), the undersigned Harraden Circle parties and Mr. Fortmiller represent themselves as passive investors lacking voting direction or investment decision-making authority, signaling no activist intent, sponsor replacement pressure, or demand to accelerate or defer a business combination. For investors tracking redemption mechanics, sponsor conduct, and deal progress, this confirms the group maintains a passive holding posture without altering the SPAC’s operational parameters. The excerpt contains zero claims attributable to any issuer chief executive, board member, or financial advisor regarding customer concentration, revenue runs, addressable market size, proprietary technology, strategic partnerships, ongoing litigation, or leadership transitions. Exact ownership percentages and total acquired shares remain unverifiable until the corresponding 13G/A schedule data is filed separately.
What changed: A Joint Filing Agreement submitted as Exhibit 99.1 to a Schedule 13G, executed on August 14, 2025, by International SPAC Management Group I LLC, Global Client Advisory Group, and Eric Swider. The instrument formally authorizes these three Reporting Persons to collectively file a beneficial ownership statement regarding Class A ordinary shares (par value of $0.0001 per share) of Renatus Tactical Acquisition Corp I, a Cayman Islands company, and grants mutual permission to submit all future amendments on each other's behalf. The filing updates the regulatory reporting arrangement among the listed holders but discloses zero movements in share counts, acquisition dates, purchase prices, voting power, or investment discretion. It does not modify the tracked $10.45 per share trust value, the May 16, 2027 business combination deadline, or the SEARCHING status. No extension proposals, redemption triggers, target negotiations, or sponsor conduct adjustments are referenced or implied. Why it matters: The document contains no operational or strategic claims regarding customers, revenue, market size, technology, partnerships, litigation, or personnel. All descriptive elements (e.g., Cayman Islands incorporation, $0.0001 par value) are administrative declarations by the filers, not assertions by RTAC management or the sponsor. For investors monitoring deal progression or shareholder economics, this filing is procedurally neutral; substantive developments will only become visible through subsequent individual or aggregated Schedule 13G/13D amendments revealing net position changes, or through definitive proxy/merger documentation detailing target selection, extension voting, or trust liquidation mechanics.
What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2025. This is the first quarterly report since RTAC completed its IPO on May 16, 2025. The filing establishes the baseline balance sheet, trust value, and capital structure of the post-IPO SPAC. It reports trust assets of $243,344,556, which corresponds to a per-share value of approximately $10.08 per public share against an initial trust deposit of $10.025 per unit. The company recognized formation and operating expenses of $445,972 and interest income of $1,240,806, yielding net income of $794,834 for the partial period. A subsequent event on July 24, 2025, discloses a $250,000 convertible promissory note issued to an investor, convertible into units at $5.00. Sponsor conduct: The Sponsor surrendered for cancellation 3,740,591 Founder Shares on March 13, 2025 and received 1,168,548 new shares on May 14, 2025, resulting in 7,011,288 Class B shares outstanding. Institutional investors and directors purchased 1,545,376 Founder Shares from the Sponsor for $3,800,032. The Sponsor also received 772,688 Private Placement Warrants transferred to non-Sponsor investors at no cost as an inducement. Why it matters: This filing establishes the baseline financials immediately post-IPO. The trust value ($10.08 per share) is confirmed. There are no imminent deadline concerns (deadline is May 2027), no extension votes, no target announced, and no material redemption activity. The post-IPO working capital ($569,066 cash outside trust) is limited but typical for a newly-public SPAC. The July convertible note is unusual: it converts at $5.00 per unit — a significant discount to the trust value — which may signal a need for cash or a potential alignment with a future target.
trust account, redeemable shares, sponsor loans outstanding +1nothing moved · 4 with no prior record of ours
- Trust account
- not previously extracted$243.3M
- Redeemable shares
- not previously extracted24.1M
- Sponsor loans outstanding
- $111Knot matched in this filing
- Mandate language
- focus its search on high potential businesses based in the U… · unchanged
The clause …“Private Placement, net of offering costs. 19 As of June 30, 2025, we had cash held in the Trust Account of $243,344,556. We intend to use substantially all of the funds held in the trust account, including any amounts representing”…
The clause …“and contingencies (Note 6) Class A ordinary shares, $ 0.0001 par value; 24,150,000 shares subject to possible redemption at $ 10.08 per share 243,344,556 - Shareholders Deficit: Preference shares, $ 0.0001 par value; 1,000,000”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: This document IS a routine compliance exhibit—a Joint Filing Statement pursuant to Rule 13d-1(k)(1) attached to a Schedule 13G/A for Renatus Tactical Acquisition Corp I. The filing text records only administrative consents from Boothbay Fund Management LLC, Boothbay Absolute Return Strategies, LP, and Ari Glass to jointly file their Schedule 13G. It reports zero changes to redemption mechanics, trust value, the business combination deadline, deal progress, or sponsor conduct. No share quantities, ownership percentages, or acquisition activity are disclosed in this exhibit. Why it matters: As a procedural consent, it carries no direct weight on capital deployment timelines or unit redemptions. It does, however, confirm that Boothbay’s entities continue maintaining a reportable equity position in the SEARCHING SPAC. Future Schedule 13G/A amendments will dictate whether this stake influences pro forma ownership calculations ahead of a merger or remains passive. Until numerical disclosures appear in subsequent filings, investors cannot assess potential impact on target selection, extension votes, or liquidation mechanics. All observations regarding future influence derive from standard SEC reporting sequences, not from this consent exhibit.
What changed: Quarterly report (Form 10-Q) for Renatus Tactical Acquisition Corp I for the period ended March 31, 2025, filed June 25, 2025. The report covers the company's pre-IPO period and includes subsequent events for the IPO consummated on May 16, 2025. This is the first quarterly report after the IPO. The financial statements as of March 31, 2025, reflect only deferred offering costs ($1.22M), accrued offering costs ($1.11M), and a related party payable ($111K), with no cash and a working capital deficit of $1.20M. The IPO closed after the quarter on May 16, 2025, raising $241.5M in gross proceeds plus $3.82M from private placement warrants, with $10.025 per unit placed in trust. Sponsor shares were surrendered and reissued; the sponsor now owns 7,011,288 Class B shares. No business combination has been announced. Why it matters: This filing establishes the baseline trust value ($10.025 per share, but the user notes $10.45 per share, likely after interest), redemption mechanics (24-month deadline, extendable to 30 months), and sponsor commitment. It shows the company is now publicly traded and searching for a target. The working capital deficit pre-IPO indicates the company relied on the IPO proceeds for liquidity. The filing also details warrant terms and lock-up provisions.
What changed: Form 3 initial statement of beneficial ownership of securities, classified as a routine compliance exhibit. The filing states that Director Lambert Randall Thomas Jr. reported no non-derivative transactions or holdings. No adjustments to the trust account ($10.45 per share), the redemption deadline (2027-05-16), extension provisions, or business combination progress are disclosed within this submission. Why it matters: This filing functions as a compliance exhibit establishing the baseline for insider position reporting before subsequent Forms 4. Because it records zero non-derivative equity movements or holdings for the named director, it provides no data on sponsor funding, side agreements, or pre-deal share accumulation that typically influences redemption calculus or deal execution. Investors tracking the $10.45 trust amount and 2027-05-16 timeline should monitor future filings for any deviation from this zero-disclosure posture, as subsequent entries would signal shifts in director alignment, capital commitment, or exit positioning ahead of the redemption window.
What changed: A Form 8-K Current Report accompanied by Exhibit 99.1, a corporate press release announcing the separate trading commencement of securities underlying the initial public offering units. The press release, dated June 4, 2025 and signed by Chief Executive Officer Eric Swider, announces that holders of the company’s IPO units may elect to separately trade the underlying Class A ordinary shares and redeemable warrants commencing June 9, 2025. Separately traded shares will carry the Nasdaq ticker RTAC, warrants will trade as RTACW, and unsplit units will continue as RTACU. The filing specifies that each unit comprises one Class A ordinary share with a par value of $0.0001 and one-half of one warrant exercisable for one share at an exercise price of $11.50. Management stated that no fractional warrants will be issued upon separation and directed shareholders to have their brokers contact transfer agent Odyssey Transfer and Trust Company to facilitate the split. The registrant also notes it recently changed its conforming name from Renatus Yorkville Tactical Acquisition Corp I and previously Renatus Tactical Acquisition Corp I. Why it matters: This unbundling action alters the trading mechanics for the listed instruments without touching the underlying trust corpus or statutory redemption timeline. Shareholders gain the ability to divest equity, warrants, or units independently, which changes liquidity dynamics and price discovery before any potential business combination. The company narrowed its stated acquisition mandate, stating management intends to pursue targets in cryptocurrency, blockchain, data security, and dual-use technologies markets. Sponsor conduct is highlighted through the explicit instruction on broker-to-transfer-agent mechanics and the confirmation that the registration statement was declared effective on May 14, 2025, with Clear Street acting as sole book-running manager. None of these disclosures modify the per-share trust redemption amount or alter the deadline to complete a transaction.
What changed: A Form 8-K announcing the completion of the company's initial public offering and private placement, accompanied by an audited balance sheet and detailed financial statement notes as of May 16, 2025. The filing confirms that on May 16, 2025, Renatus Tactical Acquisition Corp I closed its IPO of 24,150,000 units at $10.00 per unit, fully exercising the underwriter's over-allotment option. Concurrently, the company closed a private placement of 3,821,591 warrants at $1.00 per warrant. These proceeds resulted in $242,103,750 being placed in the trust account, establishing an initial trust value of $10.025 per public share. The combination period is defined as 24 months from the IPO closing, or up to 30 months if the company exercises its full extension right. The sponsor's founder share count was retroactively adjusted after surrendering 3,740,591 shares and receiving 1,168,548 new shares, leaving 7,011,288 Class B ordinary shares outstanding. The company also noted a corporate name change from Renatus Yorkville Tactical Acquisition Corp I effective in January 2025. Why it matters: This filing officially triggers the SPAC's operational clock and locks the exact per-share redemption math for public investors. The $10.025 trust deposit defines the baseline liquidity available for redemptions or liquidation events, with interest only releaseable to cover franchise and income taxes or permitted withdrawals. Critically, the document outlines a sponsor indemnification pledge intended to shield the trust from third-party claims reducing the balance below $10.025 per share, but management explicitly notes that the sponsor's only identified assets are securities in the company itself, leaving no independent financial reserve to back that guarantee. The filing also flags material execution risks, warning that geopolitical instability, trade tensions, and sanctions related to Russia, Ukraine, and the Middle East could materially and adversely affect the company's ability to identify and close a target within the mandated timeframe.
What changed: This document is a Joint Filing Statement pursuant to Rule 13D-1(K)(1), submitted as an exhibit to a Schedule 13G beneficial ownership report. First, it identifies the submission as a routine compliance exhibit rather than a merger agreement, resignation, investor presentation, or litigation. Second, regarding mechanics, it contains no updates to the $10.45 per-share trust allocation, no modifications to the 2027-05-16 business combination deadline, no proposed extensions, no amendment to redemption procedures, no deal progress, and no new disclosures regarding sponsor conduct. Third, substantively, it reports zero claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; it solely documents mutual consent among Boothbay Fund Management LLC, Boothbay Absolute Return Strategies, LP, and Ari Glass to aggregate their Schedule 13G filings under SEC rules. Why it matters: While procedurally standard, the joint filing structure clarifies how related investment vehicles and an individual are consolidating disclosure responsibilities for RTAC shares. The complete absence of supplemental exhibits, amendments, or statements of intent signals that the named parties do not currently perceive a threshold change in their position, nor are they positioning ahead of the search period expiration or trust liquidation timeline. For investors tracking RTAC, this confirms ongoing passive or non-control beneficial ownership without altering the existing redemption calendar, trust trajectory, or acquisition expectations.
What changed: Form 3 — insider ownership report, classified in its own terms as a routine compliance exhibit filed by an issuer’s director to initially declare beneficial security holdings or assert an exemption therefrom. The filing states that Director Fattal Mattan reported ‘No non-derivative transactions or holdings’ of Renatus Tactical Acquisition Corp I securities. This produces no modification to trust account administration, shareholder redemption mechanics, extension voting schedules, sponsor lock-up duration, or business combination diligence pacing. Why it matters: Investors tracking insider alignment and capital preservation detect zero equity movement that could alter dilution math, warrant exercise windows, or underwriter placement commitments, leaving the target search and cash management framework operationally static. The document supplies no operational, financial, or contractual disclosures; every stated condition derives exclusively from the SEC submission’s boilerplate declaration.
What changed: 8-K and associated exhibits filed by Renatus Tactical Acquisition Corp I upon the closing of its initial public offering, including the underwriting agreement, amended charter, warrant agreement, trust agreement, registration rights agreement, insider letters, administrative services agreement, indemnity agreement, convertible note, and press release. Renatus Tactical Acquisition Corp I completed its IPO on May 16, 2025, selling 24,150,000 units (including full exercise of the over-allotment option) at $10.00/unit for gross proceeds of $241,500,000. A total of $242,103,750 from the IPO and private placement was deposited into the trust account ($10.025 per public share). The trust value is $242,103,750 with 24,150,000 public shares. The deadline for a business combination is 24 months from the closing (May 16, 2027), extendable by the board by up to two three-month periods to May 16, 2027 at the latest, without shareholder approval. Director Devin Nunes, through an entity he controls, holds an interest in the sponsor. The sponsor purchased 3,821,591 private placement warrants at $1.00 each, generating $3,821,591. Why it matters: This is the IPO closing filing for a new SPAC. It establishes the trust value ($10.025/share), the 24-month deadline (May 2027), and the board's unilateral extension capability. The sponsor structure includes Devin Nunes, with its sponsor having a significant financial interest.
What changed: A final prospectus (Form 424B4) registering the initial public offering of $210,000,000 consisting of 21,000,000 units, each comprising one Class A ordinary share and one-half of one redeemable public warrant, priced at $10.00 per unit, with delivery scheduled on or about May 16, 2025. The document establishes the trust account funding mechanics at $10.025 per unit, totaling $210.5 million (or $242.1 million if the underwriters' over-allotment option is fully exercised). Why it matters: These structuring details material shift standard SPAC risk profiles for redeemer and hold shareholders. The $10.025 per-unit trust deposit eliminates the $10.00 baseline convention, while the $0.004 founder share cost combined with anti-dilution conversion rights generates immediate, substantial implied dilution documented in the prospectus. By removing the public shareholder redemption opt-out during board-approved extensions, the filing strips retail investors of their primary leverage mechanism to pressure sponsors toward liquidation or higher trust payouts.
What changed: A Schedule 13G beneficial ownership report and its accompanying Exhibit A, a Joint Filing Agreement. According to the Joint Filing Agreement executed on May 16, 2025, by Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; and Frederick V. Fortmiller, Jr., the parties are electing to file a single Schedule 13G for their combined beneficial ownership of Renatus Tactical Acquisition Corp I shares under Rule 13d-1(k). Bearing directly on your tracked mechanics—redemption deadlines, trust value, extensions, deal progress, and sponsor conduct—this filing provides zero updates. It discloses no share quantities, ownership percentages, acquisition costs, redemption mechanics, trust account references, business combination status, or sponsor governance shifts. It does not modify, extend, or comment on the timeline, liquidity parameters, or trust preservation you monitor. Why it matters: Beyond the mechanical silence, the document substantively identifies the blockholder reporting configuration. Six Harraden-Circle affiliated vehicles and Mr. Fortmiller are consolidating their disclosure obligations under one filing, which clarifies how their aggregated economic stake will be publicly tracked moving forward. The filing makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. It is a routine compliance exhibit that confirms coordinated ownership aggregation by these specific investors without introducing new valuation inputs, redemption triggers, or extension procedures. Its practical relevance is limited to transparency around who controls the reported beneficial ownership position, offering no actionable data for redemption modeling or deal progression assessment.
What changed: Form 8-A/A (Amendment No. 1) for registration of certain classes of securities pursuant to Section 12(b) of the Securities Exchange Act of 1934. This is a routine administrative correction that solely fixes the registrant’s name on the signature page of the original Form 8-A filed May 14, 2025. The filing explicitly states the remainder of the original registration is repeated without any changes, meaning there are no adjustments to the SPAC’s trust account valuation, redemption timeline, business combination status, or sponsor agreements. The registered securities—Units (each consisting of one Class A Ordinary Share and one-half of one redeemable warrant), Class A Ordinary Shares at a par value of $0.0001 per share, and whole warrants exercisable at $11.50 per share—remain structurally identical to the original filing. Why it matters: For investors tracking redemption calendars, trust distributions, extensions, or acquisition progress, this filing introduces zero mechanical shifts. According to the Company’s amendment, the warrant exercise price remains $11.50 and the official securities description is preserved by cross-referencing the initial Registration Statement on Form S-1 (File No. 333-285842), originally filed March 14, 2025. Per the signing authority, Chief Executive Officer Eric Swider executed the amendment. Because the document functions exclusively as a clerical amendment to exchange listing paperwork, it does not trigger shareholder votes, alter cash reserves, or provide evidence of target identification, pipeline development, or sponsor governance changes.
What changed: Routine compliance exhibit: SEC Form 3 insider ownership report [0001140361-25-019076] for Renatus Tactical Acquisition Corp I. The Form 3 explicitly discloses 'No non-derivative transactions or holdings reported' for reporting person Alexander Cano (Chief Operating Officer), confirming zero movement in the officer’s equity position. Why it matters: This filing does not advance the 2027-05-16 redemption deadline, modify the $10.45 trust/share, trigger any extension provision, or reflect sponsor conduct relative to a business combination. According to the document, it contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or additional personnel disclosures, meaning it provides no substantive signal on deal progress or executive alignment. The filing functions solely as a regulatory baseline for an officer whose holdings remain unchanged, offering no mechanical impact on the SPAC’s redemption calendar or capital structure.
What changed: A Form S-1 Registration Statement filed pursuant to Rule 462(b) to register additional public offering units immediately upon the effectiveness of the prior registration. According to the filing, the Registrant registers 4,025,000 additional units, including 525,000 subject to the underwriter’s option to purchase additional units. Each unit consists of one Class A ordinary share and one-half of one redeemable public warrant, with whole warrants exercisable to purchase shares at $11.50 per share. The filing incorporates by reference the Prior Registration Statement (File No. 333-285842), which was initially filed on March 14, 2025, amended on April 21, 2025, May 6, 2025, May 9, 2025, and May 13, 2025, and declared effective on May 14, 2025. The Registrant certifies that a wire transfer for the required filing fee will be instructed to U.S. Bank no later than the close of business on May 15, 2025. Principal executive office address is listed as 1825 Ponce de Leon Blvd, Suite 260, Coral Gables, FL 33134. Legal counsel includes Paul Hastings LLP at 200 Park Avenue, New York, NY 10166, and 2050 M Street NW, Washington, DC 20036, alongside Latham & Watkins LLP at 1271 Avenue of the Americas, New York, NY 10020, and Maples and Calder (Cayman) LLP. Consent documents are attached from Adeptus Partners, LLC. Executives Eric Swider and Ian Rhodes signed the statement. No provisions altering the trust account, redemption mechanics, extension windows, or business combination targets are disclosed. Why it matters: As a Rule 462(b) effectiveness filing, this document confirms the immediate availability for sale of additional units, which increases the total registered capital base and establishes the final warrant structure referenced in the offering. The certification of the filing fee payment confirms administrative closure without procedural lag. While the filing does not amend the search status or corporate timeline, it finalizes the registration footprint and defines the $11.50 warrant exercise price that will govern downstream dilution and capital raising mechanics if the business combination or additional offerings proceed.
What changed: SEC Rule 461 correspondence requesting acceleration of the effective date of a Form S-1 registration statement. Renatus Tactical Acquisition Corp I, via Chief Executive Officer Eric Swider, requests the registration statement (File No. 333-285842) be declared effective at 4:00 p.m. Eastern Time on Wednesday, May 14, 2025. The filing does not amend redemption procedures, modify trust account mechanics, or extend the stated liquidation window. Outside counsel Paul Hastings LLP is designated for post-effectiveness coordination. Why it matters: This procedural submission advances administrative registration timelines while leaving the redemption calendar, trust distribution rules, and target-search phase entirely unadjusted. The text contains zero assertions regarding revenue, market size, customer contracts, technology, strategic partnerships, pending litigation, or operational personnel changes beyond the executive signature line. Because it discloses no business-combination targets, underwriter arrangements, or PIPE commitments, it carries no immediate economic weight for holders tracking redemptions or extensions.
What changed: A routine compliance exhibit — an SEC Form 3 initial statement of beneficial ownership for issuer Renatus Tactical Acquisition Corp I, submitted by reporting person Devin G. Nunes, identified as a director. The filing explicitly states 'No non-derivative transactions or holdings reported.' Per this submission, there is no change to the director’s reported equity position, and the document contains no updates regarding redemption deadlines, trust share values, extension status, deal progress, or sponsor conduct. It further contains no substantiated claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel actions beyond the directorship attribution. Why it matters: Because this Form 3 certifies zero insider transaction activity, it does not generate forward-looking signals about shareholder redemption pressure, combination timelines, or management conviction. For investors tracking the SPAC’s lifecycle, the filing functions purely as a regulatory disclosure record. The absence of reported equity movements neither advances nor impedes the current SEARCHING status or the associated trust mechanics, and requires no calendar, valuation, or behavioral adjustments.
What changed: A Form 3 (Initial Statement of Beneficial Ownership) filed by Director Jeffrey Andrew Smith for Renatus Tactical Acquisition Corp I, formally declaring no non-derivative transactions or holdings. The filing confirms a routine Form 3 submission but discloses zero insider equity activity. There is no update to redemption mechanics, trust account administration, extension procedures, target acquisition status, or sponsor trading behavior ahead of the May 16, 2027 deadline. Why it matters: The document contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. As a compliance exhibit reporting zero insider transactions, it provides no measurable signal of management confidence, capital deployment intent, or alignment with public shareholders. The stated trust value of $10.45 per share remains unaffected by this filing, and because the SEC form itself reports no holdings or transfers, no inference can be drawn regarding sponsorship conduct or conversion timelines. Investors should treat this as a procedural filing that requires no adjustment to the redemption calendar or due diligence focus until material developments—such as amendment filings, proposed business combinations, or extension vote notices—are disclosed by the issuer.
What changed: Underwriter’s Acceleration Request Letter submitted pursuant to Rule 461 of the Securities Act of 1933, formally requesting the SEC to declare the Form S-1 Registration Statement (File No. 333- 285842) effective on May 14, 2025, at 4:00 p.m. Eastern Standard Time. The filing reports zero changes to redemption deadlines, trust account valuations, extension elections, deal progress, or sponsor conduct. Why it matters: For investors monitoring RTAC, this document serves exclusively as an administrative timing notice that locks in the legal effectiveness window for the active S-1 offering without altering the May 16, 2027 business combination deadline or the $10.45 per share trust value. Every operational assertion originates from Clear Street LLC (executed by Managing Director Ryan Gerety, with counsel notifications copied to Patrick H. Shannon and R. Charles Cassidy III of Latham & Watkins LLP) regarding distribution logistics and exchange act compliance.
What changed: Form 8-A for registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. The registrant formally registered Units, Class A Ordinary Shares, and whole redeemable warrants for trading on the Nasdaq Global Market. Regarding redemption mechanics, trust preservation, deadline management, extension voting, and sponsor conduct, the filing introduces no changes or updates. Why it matters: As a routine listing confirmation, this submission does not advance redemption calendars, adjust trust valuations, initiate extension periods, or disclose target pursuit progress. Because the registrant offers no commentary on customer bases, revenue streams, addressable markets, strategic pivots, proprietary technology, third-party partnerships, ongoing litigation, or executive transitions beyond the signing officer’s title, the document provides no actionable intelligence for investment timing or redemption calculations.
What changed: An SEC Form 3 initial beneficial ownership compliance report. The filing discloses no non-derivative transactions or holdings adjustments for Chief Financial Officer Ian Rhodes. This leaves the entity’s pre-merger mechanics, search-phase trajectory, and scheduled termination timeline entirely unaltered by this submission Why it matters: In a SEARCHING phase, an uneventful Form 3 confirms the chief financial officer has maintained a static equity position. Sponsor and executive holdings typically shift ahead of business combination negotiations or extension voting; the absence of activity here removes any near-term catalyst tied to insider capital movement. The submitted text contains zero assertions regarding customer pipelines, revenue projections, market sizing, technological roadmaps, partnership alignments, litigation posture, or executive personnel changes
What changed: SEC Form 3 — Insider Ownership Report. The filing, dated 2025-05-14, reports that Swider Eric—identified by the document as director, Chief Executive Officer, and 10% owner—had no non-derivative transactions or holdings reported. Why it matters: For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, this confirms zero changes to direct insider equity. The mechanical parameters remain unchanged: the SPAC stays in SEARCHING mode, the trust value holds at $10.45 per share, and the liquidation deadline remains 2027-05-16. Because the filer attributes the executive titles and ownership percentage to Swider Eric, the submission serves as a routine compliance baseline rather than a signal regarding extension voting, merger timing, or capital deployment. Aside from those stated roles, the document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel movements.
What changed: A SEC Comment Response Letter (CORRESP) submitted by Paul Hastings LLP on behalf of Renatus Tactical Acquisition Corp I, responding to Staff comments dated May 12, 2025 on Amendments No. 2 and 3 to the Form S-1 Registration Statement, while concurrently filing Amendment No. 4. The Registrant implemented Staff-directed revisions to founder share disclosures and insider agreements. Disclosure on pages 1–3, 120, and 156 was updated to identify the entity controlled by Mr. Nunes that holds the remaining 50% economic interest in Sponsor HoldCo's founder shares. Why it matters: This filing addresses ongoing SEC registration mechanics governing insider equity compensation and exhibit referencing; it does not modify the redemption calendar, adjust the trust value per share, or extend the 2027-05-16 business combination deadline. The document contains no claims regarding customers, revenue, market size, corporate strategy, technology, partnerships, or pending litigation.
What changed: Amendment No. 4 to Form S-1 Registration Statement for the initial public offering of Renatus Tactical Acquisition Corp I, a blank-check SPAC still searching for a business combination target. The filing includes the prospectus and exhibits (insider letter agreements, warrant purchase agreement, convertible note, indemnity agreement, consent of auditor). The filing updates the registration statement to reflect the surrender and cancellation of 3,740,591 founder shares by the sponsor on March 13, 2025 (retroactively restated in the financial statements), and includes auditor consent dated May 13, 2025. Exhibits 10.1 (Insider Letter Agreement), 10.2 (Non-Sponsor Investor Letter Agreement), 10.7 (Private Placement Warrants Purchase Agreement), 10.8 (Indemnity Agreement), and 10.10 (Convertible Promissory Note) are filed as new exhibits. The prospectus remains substantially the same as the prior version, detailing the $175M IPO of 17.5M units at $10.00, focusing on U.S. businesses in crypto/blockchain, data security, and dual-use technologies. The SPAC has not yet selected a target. Why it matters: This amendment moves the SPAC closer to completing its IPO and becoming a public vehicle with ~$175M in trust ($10.025 per unit). The updated financials show the sponsor's reduced founder share count and the working capital deficit. The exhibits formalize the lock-up agreements, voting commitments, and related-party arrangements. The filing signals that the IPO may be imminent, giving investors a clearer picture of the sponsor's terms and the risks (dilution, no target selected, conflict of interest disclosures).
What changed: SEC Staff Comment Letter regarding Amendment No. 3 to Registration Statement on Form S-1. The Division of Corporation Finance issued four regulatory comments on the May 9, 2025 filing. Comment 1 requires disclosing the entity controlled by Mr. Nunes that holds the remaining 50% of the economic interest in the founder shares held by Sponsor HoldCo. Comment 2 flags inconsistencies in the Insider Letter Agreement transfer restrictions: the narrative implies all directors and officers are restricted, yet the accompanying table excludes officers Messrs. Why it matters: As stated by the SEC staff, these comments address administrative and structural disclosures required before the registration statement can be declared effective. They do not alter the $10.45 trust per share, the 2027-05-16 deadline, or the SEARCHING status. Resolving the Nunes entity ownership clarifies actual sponsor economics and potential conflicts of interest. Defining the precise officer and director roster subject to lock-ups establishes the true post-IPO share float and vesting schedule.
What changed: SEC correspondence proposing revisions to Amendment No. 2 to Registration Statement on Form S-1 regarding founder share forfeiture mechanics, non-sponsor investor letter agreements, and updated prospectus disclosures. According to the correspondence, forfeiture of up to 762,097 founder shares contingent on underwriter over-allotment exercise will now occur solely by Sponsor HoldCo rather than pro rata. Why it matters: Per the company’s own disclosures, the concentrated forfeiture structure and the $0.004 effective founder share price give sponsors 'more of an economic incentive' to target 'riskier, weaker-performing or financially unstable business(es)' than typical sponsors would face. The registration statement indicates non-sponsor investors intend to purchase up to 1,443,182 founder shares from Sponsor HoldCo for $3,500,000 and will receive 721,591 private placement warrants transferred by Sponsor HoldCo at no additional cost.
What changed: Amendment No. 3 to a Registration Statement on Form S-1 (S-1/A) for a new SPAC initial public offering by Renatus Tactical Acquisition Corp I, which is still searching for a target. This filing updates the prospectus to reflect final pricing and underwriting terms, adds a new exhibit (the Non-Sponsor Investors Letter Agreement), and includes an updated consent from the independent auditor. This is a routine pre-effectiveness amendment. The key change is the filing of the form of Underwriting Agreement (Exhibit 1.1) and the form of Non-Sponsor Investor Letter Agreement (Exhibit 10.2), detailed for the first time. The prospectus has been updated to include a preliminary dated date of May 9, 2025, and the underwriter is named as Clear Street LLC as sole book-runner. The offering terms are fixed: 17,500,000 units at $10.00/unit, each unit consisting of one Class A share and one-half of one warrant; the trust will receive $10.025 per unit (including deferred underwriting compensation). The sponsor must deposit $1.75 million per three-month extension. The filing also confirms that Eric Swider is CEO and names the full board and officer slate. No substantive changes to business strategy, target areas, or financial projections were apparent in the revised prospectus text. Why it matters: The filing matters because it locks in the definitive terms of the IPO and provides the full text of the Non-Sponsor Investor Letter Agreement, which governs the conduct of non-sponsor holders of founder shares. The SPAC features a strong management team (including Devin Nunes) with prior SPAC experience (DWAC/TMTG). The trust per-share value is $10.025, and the sponsor's low-cost founder shares ($0.004/share) create significant dilution risk for public shareholders. The SPAC has 24 months (extendable to 30) to complete a deal, with a deadline of May 2027 (or later if extended). The underwriter has a conflict of interest, receiving deferred compensation contingent on a deal.
What changed: Securities and Exchange Commission correspondence letter (CORRESP) from Paul Hastings LLP attorney Gil Savir to the Division of Corporation Finance, submitting the Registrant’s written responses to staff comments dated May 2, 2025, regarding Amendment No. 1 to the Registration Statement on Form S-1 for Renatus Tactical Acquisition Corp I, and concurrently filing Amendment No. 2. The filing reports no amendments to the trust per-share value of $10.45, the SEARCHING designation, or the 2027-05-16 liquidation deadline. Why it matters: Gil Savir of Paul Hastings LLP explains that the $6,000 monthly CFO compensation establishes a recurring operational cash drain that reduces the available trust capital heading toward the 2027-05-16 deadline, though the amendment does not invoke extension provisions or alter redemption mechanics. The SEC Staff initially flagged the absence of detailed background on executives Messrs. Nunes and Smith, requesting descriptions of their prior involvement with Yorkville Acquisition Corp.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.